Get the Stockscreener App
10.15
3.67%
-0.40
Delcath Systems Inc stock is traded at $10.15, with a volume of 112.16K.
It is down -3.67% in the last 24 hours and up +13.30% over the past month.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$10.55
Open:
$10.43
24h Volume:
112.16K
Relative Volume:
0.28
Market Cap:
$349.71M
Revenue:
$85.23M
Net Income/Loss:
$2.70M
P/E Ratio:
161.62
EPS:
0.0628
Net Cash Flow:
$20.97M
1W Performance:
-9.18%
1M Performance:
+13.30%
6M Performance:
+4.56%
1Y Performance:
-16.70%
1-Day Range:
$10.15
$10.47
1-Week Range:
$10.15
$11.20
52-Week Range:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.15 | 363.50M | 85.23M | 2.70M | 20.97M | 0.0628 |
ABT
Abbott Laboratories
|
91.91 | 163.10B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
312.87 | 123.10B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
79.60 | 105.15B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.38 | 86.87B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.44 | 47.44B | 6.30B | 1.07B | 1.34B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Do Options Traders Know Something About Delcath Systems Stock We Don't? - MSN
BlackRock (NASDAQ: DCTH) holds 1.73M DELCATH shares, 4.98% - Stock Titan
Implied volatility surging for Delcath Systems stock options - MSN
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing - Stock Traders Daily
Delcath Systems to Host First Quarter 2026 Earnings Call - BioSpace
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates - MSN
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
JPMorgan Chase & Co. Decreases Position in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems (NASDAQ:DCTH) Stock Price Up 0.3%Time to Buy? - MarketBeat
Delcath (DCTH) Stock Adds to Position (-1.46%) 2026-04-16Stock Trading Network - Xã Thanh Hà
(DCTH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
DCTH SEC FilingsDelcath Sys 10-K, 10-Q, 8-K Forms - Stock Titan
Is Delcath (DCTH) Stock Discounted Now | Price at $10.18, Up 1.34%Bearish Pattern - UBND thành phố Hải Phòng
Risk Off: Can Delcath Systems Inc expand into new markets2026 Fed Impact & Safe Entry Zone Tips - baoquankhu1.vn
Aug Decliners: What are the future prospects of Delcath Systems IncWeekly Investment Report & Weekly High Return Forecasts - baoquankhu1.vn
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2025 earnings call transcript - MSN
Implied Volatility Soars for Delcath Systems Options - Bitget
Implied Volatility Surging for Delcath Systems Stock Options - TradingView
Is Delcath Systems Inc a strong candidate for buy and holdWeekly Trade Report & Verified Technical Signals - baoquankhu1.vn
Delcath Systems (DCTH) Gains Recognition in Clinical Guidelines - GuruFocus
Delcath therapy included in European uveal melanoma guidelines By Investing.com - Investing.com Australia
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma - BioSpace
Delcath therapy included in European uveal melanoma guidelines - Investing.com
Is Delcath (DCTH) Stock Safe to Buy Now | Price at $9.76, Up 1.35%Stock Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Bear Alert: Is Delcath Systems Inc a strong candidate for buy and holdMarket Weekly Review & Growth Focused Stock Reports - baoquankhu1.vn
Aug Levels: Is Delcath Systems Inc a strong candidate for buy and holdShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
EBIT per share of Delcath Systems, Inc. – MUN:DV3R - TradingView
DCTH PE Ratio & Valuation, Is DCTH Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
DV3R.SG,0P0000X679,0 (DV3R.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Responsive Playbooks and the DCTH Inflection - Stock Traders Daily
Delcath Systems Inc. (US24661P8077.SG) Balance Sheet - Yahoo! Finance Canada
Delcath (NASDAQ: DCTH) seeks approval to expand 2020 equity incentive plan - Stock Titan
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting - BioSpace
[ARS] DELCATH SYSTEMS, INC. SEC Filing - Stock Titan
DV3R.SG,0P0000X679,0 (DV3R.SG) stock price, news, quote and history - Yahoo Finance UK
Delcath Systems (DCTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Decliners Report: What are the future prospects of Delcath Systems IncProduct Launch & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Are options traders betting on a big move in Delcath Systems stock? - MSN
Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030 - GlobeNewswire
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Q3 2025 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Risk Analysis: Is Delcath Systems Inc backed by strong institutional buyingForecast Cut & Daily Stock Trend Watchlist - baoquankhu1.vn
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):